Updated Q3 2026 by CT Acquisitions.

Private equity expansion financing definition: what LMM owners actually get, cost, and how to run the process

The private equity expansion financing definition is a minority equity investment made by a private-equity, growth-equity, or family-office sponsor into an already profitable operating business, typically writing a check between $10 million and $150 million in exchange for 15% to 45% of the equity, with the cash used for organic growth, tuck-in acquisitions, a shareholder liquidity slice, or a mix. It sits between venture capital (unprofitable, majority sold over rounds) and control private equity (buyout, 60%+ purchased, founder often replaced). For a lower-middle-market owner running a $10M to $200M revenue business with $2M to $25M of EBITDA, expansion financing is often the first outside institutional check, and the terms that get accepted in month two shape ownership, board seats, and exit optionality for the next five to seven years.

What is private equity expansion financing?

The private equity expansion financing definition covers a minority equity investment, typically $10M to $150M, made by a growth-equity or family-office sponsor into a profitable business running 15%+ revenue growth. It funds organic hiring, product build-out, tuck-in acquisitions, or a partial owner cash-out, without a change of control. Summit Partners has deployed this exact strategy across 550+ investments since 1984, per the firm’s public overview.

The label matters because the industry uses at least four terms for the same product. Wall Street desks call it expansion financing. Sponsors call it growth equity. Investment banks call it a minority growth round or a minority recap when the owner takes chips off the table. Family offices sometimes call it structured growth capital when the deal is preferred stock rather than common. The check writer, the check size, and the mechanics are close enough that a founder shopping the market should treat the labels as translation, not distinction.

What actually distinguishes expansion financing from every other capital source is a specific set of criteria: the target company is already generating meaningful cash flow, the sponsor takes a minority stake, the founder keeps operating control, and the exit thesis is a single sale event three to seven years out rather than a series of markup rounds. That framing is why growth equity as a fund category managed $1.1 trillion of AUM globally by year-end 2024, according to Bain & Company’s 2025 Global Private Equity Report, and why LMM operators increasingly treat it as a legitimate alternative to a full sale.

For a founder-owner, the practical mental model is this: you sell a slice of the company to a professional investor, you take some cash home, you put the rest on the balance sheet to fund the next phase, and you keep running the business. The sponsor prices the equity, joins the board, and expects to sell alongside you in five to seven years. Everything else in this guide is a variation on that structure.

Who typically uses expansion financing?

Expansion financing is used by profitable LMM operators, usually $10M to $200M in revenue and $2M to $25M in EBITDA, who need capital to fund growth without giving up control. Typical borrowers include vertical SaaS companies, healthcare services roll-ups, industrial specialty manufacturers, and family-owned distributors. JMI Equity’s portfolio of $10M to $75M ARR software businesses is a textbook fit, as documented on the firm’s portfolio page.

The audience for this product is deliberately narrow. A pre-revenue software team is not a candidate; that is a Series A conversation with Sequoia or Benchmark. A retail investor writing $10K checks is not a candidate; that is a Wefunder audience. A $500M revenue platform selling for $1.5B is not a candidate either; that transaction is a control buyout run by KKR, Blackstone, or Bain Capital. Expansion financing lives in the middle, in a segment that Cambridge Associates has estimated at roughly 200,000 US operating businesses meeting the LMM definition, per its long-running private-investments research.

Sector fit varies but concentrates in a handful of verticals. Growth equity has historically loved vertical SaaS with $10M+ of ARR growing 25%+ (see JMI Equity, Silversmith Capital, Mainsail Partners). Healthcare services roll-ups anchored in physician practice management or specialty behavioral health draw firms like Nautic Partners, Shore Capital, and Webster Equity. Industrial specialty and precision-machining rollups draw May River Capital, CenterOak Partners, and RFE Investment Partners. Consumer branded goods with $20M+ in revenue and clean unit economics draw L Catterton and TSG Consumer Partners. If your business is in one of these lanes with real profitability, you are the target audience.

Owner intent matters as much as sector. Expansion financing works for the operator who wants to keep running the company, sees a clear five-year growth path, and would benefit from a professional investor at the table for the acquisition-integration, hiring, or reporting rigor. It does not work for the owner ready to fully retire, and it does not work for the owner unwilling to accept board oversight and quarterly reporting cadence. If you are closer to full retirement, review our sell-side M&A advisory guide instead.

How does expansion financing compare to alternatives?

Expansion financing sits between debt (no dilution, coupon and covenants) and control buyouts (60%+ sold, founder often replaced). Compared to venture capital, it targets already-profitable businesses and dilutes once rather than over multiple rounds. Compared to mezzanine debt, it has no coupon and no maturity, and adds a professional board partner. Bain’s 2025 report documented $1.6 trillion of PE dry powder globally at year-end 2024, meaning capital is abundant and terms are negotiable.

Capital source	Dilution / cost	Control impact	Best fit for LMM
Senior secured loan (unitranche)	0% dilution; SOFR + 500-750 bps; 3.0x-4.5x leverage	Covenants, no board	Cash-flow-strong business with organic growth plan
Mezzanine debt	0-5% warrant dilution; 11-14% coupon; 5-7 year term	Observer seat typical	Acquisition financing when senior maxed out
Expansion / growth equity	15-45% dilution; no coupon; long-dated	1-2 board seats; protective provisions	Business needing capital plus a partner for scale
Control private equity buyout	60%+ equity sold; owner typically rolls 20-40%	Sponsor controls board; new CEO possible	Owner ready to exit control and monetize
Venture capital (Series B/C)	15-25% per round; multiple rounds diluting to 60%+	Board seats each round; preferred stack	Pre-profit software or biotech scaling on losses
Structured preferred (family office)	Preferred coupon 6-10% plus 10-25% common warrants	Observer or single board seat	Owner wanting minimal dilution with some liquidity

The comparison that most LMM owners get wrong is between growth equity and mezzanine. Mezzanine debt from firms like Prudential Capital Group, NewSpring Mezzanine, or Audax Private Debt looks cheaper because there is no dilution and a fixed coupon in the 11% to 14% range. The catch is the coupon is cash-pay or PIK, which drains free cash flow, and the debt has a maturity date. Growth equity has no coupon and no maturity, and the sponsor absorbs the operating risk if the growth plan misses. For a business with lumpy cash flow or an acquisition-heavy plan, that risk-sharing is worth the dilution. For a comparison specifically on the mezzanine question, see our mezzanine debt for acquisitions guide.

The second comparison that trips up owners is expansion financing versus a control buyout. If a buyout sponsor is offering 7.5x EBITDA for 100% of the equity and a rollover, and a growth-equity sponsor is offering 8.5x for 30% and a shareholder liquidity slice, the growth deal often nets more to the founder over the five-year hold because the retained equity typically compounds at the growth rate of the business. That math obviously depends on execution, but it explains why so many LMM owners in 2024-2026 have shifted from full-sale processes to dual-track processes. For deeper reading, see our head-to-head growth equity vs private equity guide.

When does expansion financing make sense?

Expansion financing makes sense when the business is already profitable, growing at 15%+ organically, and has a clear plan to deploy capital productively over 24 to 36 months. Common triggers include a $10M+ acquisition target, geographic expansion, an ERP or product rebuild, or a shareholder liquidity event. Vista Equity Partners disclosed its 2024 investment into Model N as a classic expansion round to fund the company’s transition into AI-native life-sciences workflow tooling, per Vista’s news page.

Fit criteria for expansion financing tighten in the 2024-2026 market because sponsors are more selective on unit economics. The typical filter is: EBITDA of $2M or more, revenue growth of 15% or higher on a trailing-12-month basis, gross margins above 40% for services or above 60% for software, customer concentration below 25% from any single account, and a management team that will stay through the hold period. Businesses that miss on one criterion still get done, but at wider spreads and with more structure (preferred stock, participating preferred, or ratchets).

Timing also matters. A business with a single quarter of weak growth usually gets a lower valuation and more punitive terms than the same business one quarter later after a clean rebound. Sponsors underwrite off the trailing 12 months of EBITDA but negotiate multiple off the trailing quarter’s growth rate. Owners who process while momentum is decelerating routinely leave 1x to 2x of EBITDA multiple on the table. If your business is at an inflection, review the timing playbook in our lower middle market M&A advisor guide before starting.

Finally, use case matters. Sponsors want to fund a specific plan, not a general balance-sheet cushion. The pitches that get funded describe a defined acquisition pipeline, a geographic build, a product migration, or a stated goal to double revenue in 36 months. Vague “we might do M&A” plans get discounted by 10% to 20% in valuation because the sponsor cannot underwrite a use of funds it cannot model.

How much does expansion financing cost?

The cost of expansion financing is dilution rather than a coupon. Owners typically sell 15% to 45% of the equity at a valuation of 6.9x to 12x EBITDA depending on sector and growth rate. GF Data reported average LMM buyout multiples of 6.9x TTM EBITDA in Q4 2024 and 7.5x in H1 2025, with software and healthcare services trading at premiums of 2x to 4x above the industrial average, per GF Data’s published deal reports.

Capital source	Cost / dilution	Timeline to close	Ongoing burden
SBA 7(a) loan	Prime + 2.75-3.25%; 10-yr amortization	60-120 days	Monthly payment; personal guarantee typical
Bank term loan / revolver	SOFR + 275-425 bps	45-90 days	Quarterly covenant testing
Unitranche debt	SOFR + 500-750 bps; 3.0x-4.5x leverage	60-90 days	Quarterly reporting; leverage covenant
Mezzanine debt	11-14% coupon (cash or PIK); 0-5% warrants	90-120 days	Coupon drag; 5-7 year balloon
Structured preferred equity	6-10% coupon (usually PIK); 10-25% warrants	90-150 days	Redemption preference at exit
Expansion / growth equity (minority)	15-45% common or preferred dilution	120-180 days	Quarterly board; annual budget approval
Control buyout	60-100% sold; 20-40% rollover typical	180-240 days	New governance; 100-day plan

The reason dilution is the honest way to describe the cost is that a growth-equity check does not have an interest rate to compound. What compounds instead is the value the sponsor’s slice claims at exit. If you sell 30% of a business worth $50M today ($15M in) and it exits five years later at $200M, the sponsor takes $60M, or a 4.0x MOIC. You keep $140M on your 70%. Whether that is a good trade compared to a debt-financed alternative depends entirely on whether the sponsor’s dollars accelerated the plan enough to justify the equity give-up. In our advisory experience across 2024-2026 deals, the honest break-even point is a plan that would have grown at 8% to 12% without the capital and grows at 20%+ with it.

Advisor and legal fees add up. On a $50M capital raise, expect $200K to $500K in legal fees for the seller’s counsel (typically split among corporate, tax, and securities specialists), $150K to $300K for the sponsor’s diligence-fee reimbursement, and 2% to 5% of proceeds in placement or M&A advisor success fees. That is $1.2M to $3.0M of transaction cost on a $50M raise, or 2.4% to 6.0% all-in. Compared to a $50M debt raise costing $75K to $150K in fees, this is meaningfully more expensive at the transaction level and is one of several reasons operators sometimes route to debt first if the plan supports it. See our business acquisition loan primer for the debt-financing alternative.

Timeline cost is real too. Six months of a founder’s calendar dedicated to a capital raise pulls attention from customers, hiring, and operations. Data from prior CT engagements shows revenue growth typically slows 3% to 6% during an active process, which is why we structure engagements to keep the CEO in the second chair on all but the top 12 investor meetings. A discipline that separates a good process from a bad one is measured executive time in the data room.

Who are the named sponsors that provide expansion financing?

Named growth-equity and minority sponsors active in the LMM market include Summit Partners, TA Associates, General Atlantic, Silversmith Capital Partners, JMI Equity, Mainsail Partners, Frontier Growth, Serent Capital, and BV Investment Partners. Family offices like Pritzker Private Capital and Cranemere and structured-capital investors like Bain Capital Special Situations round out the market. Summit alone has invested in 550+ companies since 1984, per its portfolio page.

Sponsor	Type	Typical check size	Focus areas
Summit Partners	Growth equity	$25M-$500M	Software, healthcare, financial services, industrials
TA Associates	Growth equity	$50M-$500M	Software, services, healthcare, consumer
General Atlantic	Growth equity	$25M-$500M	Technology, financial services, consumer, life sciences
Silversmith Capital	Growth equity	$15M-$75M	Vertical SaaS, healthcare IT
JMI Equity	Growth equity	$25M-$100M	Enterprise software
Mainsail Partners	Growth equity	$10M-$50M	Bootstrapped software
Frontier Growth	Growth equity	$10M-$30M	B2B software (SaaS)
Serent Capital	Growth equity	$15M-$75M	Vertical software, tech-enabled services
BV Investment Partners	Growth equity / buyout	$25M-$75M	Business services, communications, IT services
Pritzker Private Capital	Family office	$100M-$500M	Manufacturing, services, healthcare
Cranemere	Family office	$50M-$300M	Long-hold industrials, services
Bain Capital Special Situations	Structured capital	$25M-$150M	Non-control preferred and hybrid structures

The named-sponsor list matters because sector fit and check-size fit drive whether a firm returns your first email. Summit and TA Associates, for example, are unlikely to lead a $10M round because it does not move their fund needle; the same sponsors readily lead $50M-plus rounds in their core sectors. Silversmith, Mainsail, and Frontier Growth are the natural leads for a $15M to $35M software round. JMI Equity concentrates almost exclusively in enterprise software and takes minority stakes with a documented preference for founder-led companies. Pritzker Private Capital is one of the few family offices that will underwrite an LMM growth round with no fund clock, which changes the exit conversation entirely.

2024-2026 deal comps that anchor the market include Silversmith’s $100M growth investment into legal-tech company Filevine (September 2024, per Silversmith’s investment announcement), JMI Equity’s investment into cybersecurity training platform Living Security in 2024 (per JMI’s news page), and Mainsail Partners’ 2024 recap of construction-tech platform Followup CRM (per Mainsail’s news feed). For a family-office-anchored comp, Pritzker Private Capital’s 2024 acquisition of Vertellus (specialty chemicals) illustrates the long-hold LMM growth thesis without the fund clock, disclosed via PR Newswire.

Below the named institutional sponsors sits a large market of independent sponsors and family offices without an established fund brand who nonetheless write $5M to $30M growth checks. This slice of the market has grown notably in 2024-2026 as high-net-worth capital rotated into private assets. The advantage is speed and structure flexibility; the disadvantage is uneven post-close governance. If a family-office check is on the table, compare its structure and reference calls against a fund-anchored offer before signing. Our family office vs PE buyer guide covers the trade-offs.

How does the expansion financing process work?

A typical expansion financing process runs 16 to 24 weeks in five phases: prep and materials (4-6 weeks), outreach and initial meetings (4-6 weeks), term sheet negotiation (2-3 weeks), diligence and legal (4-6 weeks), and closing (1-2 weeks). Well-run processes generate 8 to 15 term sheets from a targeted list of 40 to 80 sponsors. This mirrors the cadence documented by Axial’s deal marketplace reports across LMM processes it hosts.

1. Advisor engagement (Week 1). Sign the engagement letter, agree scope (capital raise, minority recap, or dual-track), and set the fee model. Retainer plus success fee is standard.
2. Financial cleanup (Weeks 1-3). Produce three years of quality-of-earnings-ready financials, run a QoE if not done in the last 12 months, and normalize add-backs. Sponsors will re-cut the number, so getting there first controls the narrative.
3. Positioning and CIM (Weeks 2-6). Draft the confidential information memorandum, management presentation, and financial model. Positioning is where premium multiples are earned or lost.
4. Sponsor list (Weeks 3-4). Build the target list of 40 to 80 sponsors matched by sector, check size, geography, and stage. Segment into tier-1 (must-see), tier-2 (accretive), and tier-3 (bench).
5. Teaser outreach (Weeks 5-7). Send a blind teaser to the target list. Track opens, NDA execution, and CIM delivery.
6. Management meetings (Weeks 7-10). Host 15 to 25 management meetings on video or in person. This is the highest-leverage founder time in the process.
7. Round-one bids / IOIs (Week 10-11). Receive indications of interest with valuation range, structure, and diligence conditions.
8. Second-round meetings (Weeks 11-13). Advance the top 5 to 8 sponsors into deeper site visits, customer references, and management deep-dives.
9. Term sheet negotiation (Weeks 13-15). Select the lead, negotiate exclusivity, and paper the term sheet with valuation, structure, board, protective provisions, and diligence conditions.
10. Confirmatory diligence (Weeks 15-19). Legal, financial, tax, commercial, HR, IT, and environmental diligence. Data-room hygiene matters.
11. Definitive agreements (Weeks 17-21). Purchase agreement, stockholders agreement, employment agreements, and equity incentive plan. Expect 12 to 20 turns of the docs.
12. Sign and close (Weeks 21-24). Wire, cap table update, board seating, and communications plan to employees and customers.

Two process choices most affect the outcome. First, whether the process is broad (60 to 80 sponsors) or narrow (10 to 20). Broad processes generate more competitive tension and typically produce 0.5x to 1.5x higher EBITDA multiples but consume more founder time and carry higher information-leak risk. Narrow processes preserve confidentiality and speed but leave money on the table. Second, whether the process is single-track (capital raise only) or dual-track (raise-or-sell). Dual-track processes benchmark the raise against a full-sale outcome and often surface a hybrid structure the founder would not have solicited directly.

What paperwork is required for expansion financing?

Sponsors expect a diligence package including three years of audited or reviewed financials, a quality-of-earnings report, monthly operating metrics for 36 months, customer contracts (top 20), employee agreements, IP assignments, cap table, and material litigation history. A typical growth-equity data room contains 400 to 800 documents organized in 12 to 15 folders. PwC’s deals practice publishes annual diligence-readiness surveys estimating 30% to 40% of LMM deals encounter surprises that reprice terms during confirmatory diligence.

The tables below list the standard buckets. Sellers who prepare them in the four weeks before launch dramatically compress diligence timelines and reduce the number of QoE adjustments the sponsor’s team can propose. Sellers who arrive with an unorganized data room lose two to four weeks of process time and often see 5% to 10% of headline valuation adjusted down through diligence chip-away.

• Financial. Three years of audited or CPA-reviewed financials, monthly P&L, monthly balance sheet, cash-flow statement, aged AR and AP, revenue and gross-margin cuts by customer and product, EBITDA bridge with add-backs and a supporting QoE.
• Commercial. Top-20 customer list with revenue, contract term, and renewal date; customer-concentration analysis; win-loss data; pipeline and funnel metrics; competitive positioning; product roadmap; ARR waterfall for software.
• Legal / corporate. Cap table (fully diluted), articles of incorporation, bylaws, stockholder agreements, board minutes for the last 24 months, material contracts, IP assignments, litigation summary, employment agreements for the top 15 employees.
• Tax. Federal and state tax returns for the last three years, state nexus analysis, sales-tax exposure, IRC Section 382 analysis if there are NOLs, tax-basis schedules for the founders.
• HR / people. Employee census, organizational chart, compensation benchmarking, equity plan documents, key-person insurance, benefits programs, and any severance obligations.
• Technology. Architecture diagrams, security certifications (SOC 2, ISO 27001), penetration-test summaries, incident-response documentation, open-source license inventory, third-party dependencies.

The term sheet phase produces its own paperwork. Expect a 4- to 8-page term sheet followed by a stock purchase agreement, stockholders agreement, registration rights agreement, and management rights letter. The definitive documents typically run 200 to 400 pages combined. Our what is a term sheet primer walks through the specific clauses that reallocate risk between founder and sponsor and is worth reading before you sign anything.

What are the tax and legal implications?

Expansion financing structured as a stock sale typically triggers long-term capital gains at 20% federal plus 3.8% net investment income tax, plus state tax. Owners with qualified small business stock (QSBS) held for five years may exclude up to $10M of gain under IRC Section 1202, per IRS guidance. Structuring the transaction as a partial primary raise plus secondary sale allocates the tax liability across selling and non-selling equity holders and often materially reduces the check the seller writes to the Treasury.

The single largest tax planning item in expansion financing is deciding how much of the sponsor’s check is primary (into the company) versus secondary (to existing shareholders). Primary dollars do not trigger a taxable event; secondary dollars do. A $50M round split as $30M primary and $20M secondary crystallizes a much smaller current tax bill than a $50M all-secondary recap. Owners on QSBS-eligible stock who wait for the five-year hold before the secondary can exclude the first $10M per shareholder under Section 1202, subject to the technical criteria of the statute.

State tax matters as much as federal on high-value transactions. California residents face an effective marginal capital-gains rate above 33% combining state and federal. Owners in Texas, Florida, Nevada, and Washington face only the federal rate. Multi-state operating businesses with nexus exposure across dozens of jurisdictions can create months of pre-signing cleanup work. Sponsors will not close on a state-tax exposure they cannot quantify, so pre-diligence nexus mapping is one of the highest-ROI activities in the four-week prep window.

Legal structure follows tax structure. A C-corporation seller with QSBS stock has a different playbook than an S-corp with a single class of stock and different rules again from an LLC taxed as a partnership. LLC sellers often re-form as a C-corp before the transaction to qualify for QSBS on future stock or to align with sponsor preferences, and that re-formation itself has planning implications. This is one of the few areas where saving on advisor fees is genuinely expensive.

What are the common structures and terms?

Growth equity typically uses preferred stock with a 1x non-participating liquidation preference, 3-2 or 4-2 board split (founders retain control), pro-rata rights, information rights, standard protective provisions on major decisions, and a right of first refusal on secondary sales. Participating preferred, ratchets, and full-ratchet anti-dilution are considered off-market for a healthy LMM growth round and typically signal a distressed situation. The NVCA model documents are the industry reference point, though LMM deals frequently modify heavily.

The two provisions that most affect founder economics at exit are the liquidation preference and the participation cap. A 1x non-participating preferred means the sponsor gets its money back first and then converts to common to share pro-rata; that is the market-clearing structure for a healthy round. A 1x participating preferred means the sponsor gets its money back and then also participates pro-rata on the remainder; this can shift 5% to 15% of exit proceeds from founder to sponsor on typical exit multiples. Sponsors sometimes ask for participation in weaker markets or on riskier businesses; owners should push back and price it in the valuation if they must accept it.

Board composition is the second highest-stakes term. A 3-2 board with the founder controlling three seats (self, key executive, mutually agreed independent) and the sponsor controlling two is the market benchmark for a minority round. Sponsors will negotiate for a 3-3 with the tie-breaker on major decisions defined by the protective provisions. Protective provisions usually cover budget approval, incremental debt, incremental equity issuance, sale of the company, hiring of the CEO, and material changes to compensation for the CEO. Each provision can be individually negotiated on threshold and voting standard.

Anti-dilution deserves specific attention because it looks like a technical provision until a follow-on round happens. Weighted-average broad-based anti-dilution is standard; full-ratchet anti-dilution is aggressive and shifts a disproportionate amount of dilution to founders in a down round. Given the volatility of the 2024-2026 fundraising environment, this provision has more teeth than it did five years ago and should be negotiated. Sponsors that push hard on full-ratchet without a specific reason are signaling a bearish view of the business.

What are the red flags to avoid?

Red flags in an expansion financing term sheet include participating preferred, full-ratchet anti-dilution, mandatory redemption at a fixed date, drag-along rights below 50% ownership, super-voting shares for the sponsor, and any clause tying the founder’s continued employment to the sponsor’s continued equity ownership. Also watch for undisclosed placement-agent economics and sponsors that reference-check like a buyer rather than a partner. The ILPA best-practices library catalogs many of these on the LP side and by extension informs GP behavior toward portfolio companies.

The subtler red flag is behavioral rather than contractual. Sponsors that promise to “help you fill the CEO seat” while pushing hard on protective provisions around executive hiring are signaling an intent to replace management. Sponsors that request full board control on a minority stake are also signaling that intent. Sponsors that resist standard reference calls with two or three former portfolio-company CEOs are the single loudest red flag; a healthy sponsor is happy to connect you with the founders of prior wins and losses alike, because the story on both sides shapes the market’s read on that firm.

Diligence over-reach is a related warning. Some sponsors treat pre-signing diligence as an opportunity to interview key employees and customers in ways that would be inappropriate before an exclusive period. Well-behaved sponsors gate customer references to two or three post-exclusivity, and treat employee-interview requests as narrowly-scoped and with-management-present. Diligence conduct is one of the truest previews of how a sponsor will behave on the board post-close.

Finally, watch for economics that only work in one scenario. A sponsor offering a headline valuation of 10x EBITDA with a participating preferred, a 15% IRR ratchet, and a mandatory redemption in year 5 is not actually offering 10x; the effective valuation with those terms priced in might be 7.5x. Ask the advisor to model exit waterfalls across five to ten scenarios (base, upside, downside, distress) and compare offers on the total dollars to the founder rather than on the headline multiple. This is where a good advisor earns their fee 10x over.

What are the 2024-2026 market dynamics?

The 2024-2026 market for expansion financing is defined by $1.6 trillion of PE dry powder, high but stabilizing interest rates, and record-high sponsor selectivity. Bain reported PE deal value at $602B globally in 2024, up 14% year over year, with growth equity claiming a disproportionate share, per the firm’s 2025 Global PE Report. LMM growth-equity multiples held firm at 6.9x to 8.5x EBITDA through 2024 and expanded to 7.5x to 9.5x by H1 2025 as rates began to ease, per GF Data.

The rate environment matters because sponsors underwrite debt-financed exit scenarios. The Fed’s 2024 cuts (100 bps total across three meetings) and the 2025 further easing supported multiple expansion by 0.5x to 1.5x turns in the trailing 12 months. Deals that were pricing at 6.5x in 2023 were pricing closer to 7.5x by mid-2025. That expansion has not been uniform; software and healthcare services outpaced industrials, and businesses with recurring revenue outpaced project-based businesses.

Dry powder is the other pressure point. Bain reported $1.6 trillion of global PE dry powder at year-end 2024, of which growth equity’s share was estimated at roughly $500B by PitchBook’s 2025 growth-equity report. Sponsors have both the capital and the LP pressure to deploy; the constraint is finding businesses that meet the tightened underwriting criteria. That imbalance favors well-prepared LMM sellers running competitive processes and disadvantages under-prepared sellers whose deals get repriced in diligence.

A useful cross-comparison: McKinsey’s Global Private Markets Report 2025 documented that growth-equity fundraising totaled $208B globally in 2024, down modestly from the 2021 peak of $265B but well above the ten-year median. Combined with an aging PE portfolio needing to exit, the setup for 2025-2026 is a market where sponsors need to deploy and eventually need to exit, both of which favor sellers who bring quality assets to market.

In our experience advising LMM operators raising private equity expansion financing, the single input with the most leverage on the outcome is four weeks of disciplined prep before the first sponsor call. Well-prepared processes generate 10 to 15 term sheets with a top-quartile valuation 1.5x to 2.0x above a rushed process on the same asset. Sponsors decode preparation as a proxy for how the business will report and behave on the board post-close, and price accordingly. The advisors who add the most value are the ones who tell the founder no on process shortcuts in the first month and then run a tight, competitive market in months two and three.

How does CT Acquisitions help you find the right equity partner?

CT Acquisitions runs the full process end to end: qualifying the raise, preparing materials, building the targeted sponsor list, running competitive outreach, negotiating the term sheet, and managing diligence to close. We work exclusively with LMM operators ($1M to $25M EBITDA) and maintain active relationships with 300+ growth-equity funds, family offices, and structured-capital providers. Our engagement model is built around outcome: the right partner at the right valuation on the right terms, not simply the fastest close.

What sets a specialized LMM advisor apart from a generalist investment bank is sponsor selection. A middle-market IB will run every process against a stock 60-sponsor list. A specialist rebuilds the list every time based on the business at hand, matching sector experience, check size, minority-vs-control preference, geography, post-close operating style, and hold-period expectations. Getting the wrong sponsor at the wrong valuation is worse than not raising at all; getting the right sponsor is career-defining.

CT’s process is intentionally sequenced: three weeks of financial cleanup and QoE support, two weeks of positioning and CIM drafting, four weeks of targeted outreach, three weeks of management meetings, and eight to ten weeks of diligence and close. We staff one senior banker and one associate per engagement, keep the founder in the second chair on all but the top 12 meetings, and use a live scoring model across sponsors so nothing is decided on gut. Our fee model is retainer plus success, disclosed in full at engagement.

If you are early in evaluating whether expansion financing is the right choice at all, start with the alternatives. Our guides on growth equity vs private equity, mezzanine debt for acquisitions, unitranche debt, and leveraged buyouts cover the alternatives in the same style as this piece. When you are ready to talk process, we can be under NDA and reviewing your financials inside a week.

How do you choose among competing advisors?

Evaluate advisors on four criteria: closed transactions in your sector and check size range in the last 24 months, references from three prior clients (winners and losers alike), the specific senior person who will run your deal (not just the partner who pitches you), and fee alignment with your outcome. A specialized LMM advisor with 10 to 20 closed capital raises per year in your sector is worth two multiples of EBITDA over a generalist. Ask for named-deal case studies with disclosed sponsors and outcomes.

Advisor type	Typical fit	Typical fee	Watch-outs
Bulge-bracket IB (GS, MS, JPM)	$500M+ enterprise value, IPO-track	1-2% success + retainer	Deprioritizes LMM; junior staffing
Middle-market IB (Houlihan, William Blair, Raymond James)	$100M-$1B enterprise value	1.5-3% success + retainer	Broad sector coverage; less LMM specialization
Boutique LMM IB / capital-raise specialist	$25M-$250M enterprise value	2-5% success + retainer $10-25K/mo	Sponsor list quality varies; check references
Business broker	Under $10M enterprise value	8-12% flat	Not sponsor-relationship-driven; not built for equity raises
Placement agent (equity-only)	$25M-$200M raise, no sale option	3-6% success	Not built to run a dual-track raise-or-sell
Independent advisor / former sponsor	Highly variable	Retainer + success or equity	Depth of sponsor relationships varies widely

The reference-call pattern predicts advisor quality better than any pitch material. Ask for three references: one recent win, one that took longer than expected, and one that did not close. If an advisor cannot produce a did-not-close reference and speak to it credibly, that is a warning sign; every experienced advisor has had processes fall apart, and how they handle those situations is a truer signal than the wins. On the reference calls themselves, ask two questions: was the senior banker involved through close, and would you hire the same firm again for a subsequent transaction.

Fee alignment is the last filter. A pure success fee sounds aligned but often results in the advisor pushing to close on any offer rather than the best offer. A pure retainer misaligns because the advisor gets paid whether the deal closes or not. Retainer plus success is the market standard because it funds the work while preserving upside for a great outcome. Ask specifically how the retainer credits against success, when the retainer starts, and whether the success fee is on primary capital raised only or on total transaction value. The answers materially affect what you pay.

What are the most common structures LMM sponsors use in 2026?

The three most common structures in 2026 LMM growth-equity deals are minority preferred stock (60% of deals), minority recap with liquidity slice (25%), and structured preferred with warrants (15%). The mix has shifted since 2022 as sponsors adopted more downside protection in a slower exit market. PitchBook’s 2025 mid-year growth-equity report documented rising use of structured preferred and PIK components as the market normalized, per PitchBook’s US PE Breakdown.

The minority-preferred structure remains the reference point. Sponsor buys a new class of preferred stock representing 20% to 40% of the fully diluted equity, priced at a valuation that both sides agree reflects the growth thesis. Preference is 1x non-participating, board is 3-2 or 4-2 with founders in control, protective provisions on the standard list. This structure works for a healthy business with a clear growth plan and a founder committed for the hold period.

The minority-recap structure adds a secondary component. Same preferred stock, same governance, but 20% to 60% of the total investment goes to selling shareholders rather than onto the balance sheet. The founder takes chips off the table, keeps operating control, and reduces personal financial risk. This is the structure most LMM founders in their 50s and 60s prefer because it converts illiquid equity into diversified wealth without exiting the business. Our selling to growth equity investor guide walks through the specific mechanics.

The structured-preferred structure carries more sponsor protection. Preference is 1.5x or 2x participating, or 1x non-participating with a PIK dividend of 6% to 10%, or 1x plus warrants for 10% to 25% of common. Structured preferred is used when the sponsor needs more downside protection (weaker business, riskier plan, softer market) or when the founder wants less common dilution and is willing to accept the return of capital plus a coupon before common shares in the exit waterfall. It is more expensive than plain preferred but preserves more common ownership for the founder.

What happens after the deal closes?

After close, the sponsor takes 1 to 2 board seats, sets a quarterly reporting cadence, and begins a 100-day onboarding of shared systems (financial reporting, KPI dashboards, board packet). Most sponsors do not touch operations in the first 90 days. Deployment of the raised capital typically begins in months 3 to 6 with the first acquisition or hire push. Bain’s 2025 report documented that growth-equity-backed companies grow revenue at 22% CAGR over the hold period on average, roughly 2.5x the S&P 500 median, per the firm’s 2025 Global PE Report.

The board cadence is quarterly for most minority sponsors, with monthly financial reporting and ad-hoc calls between meetings. The board packet grows in sophistication over the first 12 months as the finance team professionalizes. Founders who resist the reporting rigor tend to have friction with the sponsor by month 12; founders who embrace it tend to end year one with a better understanding of their own business than they had going in. The reporting itself is a growth accelerator when done well.

Capital deployment usually follows a defined use-of-funds document from the term sheet. If the plan called for two acquisitions in year one, the sponsor will hold the CEO accountable to that plan. Deviations require board approval. That accountability, applied well, is the single largest value-add a good sponsor provides; applied poorly, it is the largest source of friction. Founders who negotiate a broad use-of-funds framework at term sheet stage give themselves more flexibility later.

Exit planning starts earlier than most founders expect. Sponsors typically begin exit conversations in months 30 to 42 of the hold period, with a targeted sale process launched in months 48 to 60. The buyer set on exit is often a larger PE fund (upmarket sponsor recap) or a strategic acquirer, and the exit multiple in a well-executed hold is typically 1.5x to 2.5x the entry multiple. This is where the founder’s initial retained equity produces the second, larger liquidity event.

Frequently asked questions

Is private equity expansion financing the same as growth equity?

In practice, yes. Expansion financing is the older label used in banking, and growth equity is the fund-strategy label used by sponsors like Summit Partners, TA Associates, and General Atlantic. Both describe minority checks of roughly $10M to $150M written into profitable businesses running at 15% or better revenue growth. The mechanics, terms, and process are close enough to be treated as a single product for planning purposes.

How much of my company will I sell in a growth-equity round?

Typical dilution runs from 15% to 45% depending on how much capital you raise and the valuation multiple. In the 2024-2026 market, GF Data reported LMM buyouts closing at 6.9x to 7.5x EBITDA, with growth-equity minority rounds usually pricing 0.5x to 1.5x above that on quality assets. The two variables you actually control are quality of preparation and quality of the sponsor list, and both change the dilution outcome by several percentage points.

Can I take money off the table in expansion financing?

Yes. Most 2024-2026 minority recap deals include a shareholder liquidity slice of 20% to 60% of proceeds to the seller and the balance as primary capital onto the balance sheet. This is one of the defining features that separates expansion financing from a pure primary Series B or C round and is one of the most common reasons LMM founders choose growth equity over a control buyout.

Do I lose control of the board?

In a well-structured minority deal, no. Founders typically keep board control with a 3-2 or 4-2 split, with the sponsor holding one or two seats and one independent. Protective provisions on major decisions, budget approval, and future capital raises are standard and negotiable. The founder retains hire-fire authority on the executive team subject to the protective-provision framework, which is deliberately narrow.

How long does an expansion financing process take?

From advisor engagement to funded wire, a well-run process runs 16 to 24 weeks. That includes 4 to 6 weeks of prep and CIM drafting, 4 to 6 weeks of outreach and management meetings, 4 to 6 weeks of diligence and legal, and 2 to 4 weeks of closing mechanics. Cut prep and you extend diligence; process discipline in the first month compresses the total calendar meaningfully.

What is the difference between expansion financing and venture capital?

Venture capital funds unprofitable, product-stage companies that need multiple rounds and dilute to 60%+ over five years. Expansion financing writes one check into a business already generating $2M+ of EBITDA, dilutes 15% to 45% once, and targets a single exit five to seven years later. The reserve model, board dynamic, and exit path are all different, and the sponsor lists barely overlap.

What fees will I pay if I hire an M&A advisor?

LMM sell-side and capital-raise engagements typically carry a monthly retainer of $10K to $25K credited against a success fee. Success fees run 2% to 5% of enterprise value or capital raised, sometimes with a modified Lehman scale on larger deals. Placement agents on minority rounds often price closer to 3% to 6%. Fee structure varies by deal size and complexity, and the specific structure has to be negotiated in the engagement letter.

Should I take on debt instead of selling equity?

It depends on cash-flow coverage. If your EBITDA reliably supports 3x to 4x senior leverage and the growth plan is organic, unitranche or mezzanine debt often preserves ownership at a lower blended cost. If the plan requires M&A, platform build-out, or category creation, minority equity absorbs the operating risk in ways debt cannot. A dual-track process explicitly benchmarks both options and lets the founder pick the better outcome.

Related reading on CT Acquisitions

• Raise capital hub
• M&A advisory (sell-side)
• Buy-side M&A advisory
• Lower middle market M&A advisor
• Growth equity vs private equity
• Mezzanine debt for acquisitions
• Unitranche debt acquisition financing
• Selling to a growth equity investor
• Family office vs PE buyer
• What is a term sheet
• Business acquisition loan
• Leveraged buyout acquisition financing guide